Fierce Biotech July 22, 2022
Conor Hale

ForSight Robotics aims to bring the benefits of a steady, remote-controlled hand to cataract eye surgery, and, now, the Israeli startup is $55 million closer to its goal.

The company previously raised $10 million in a seed funding round last year to advance its Oryom microsurgery system to help automate the complex tasks of removing a clouded lens from the eye and replacing it with a clearer artificial one.

The new funding will be used to help move Oryom into clinical trials as well as to help develop the system for other eye-related procedures such as retinal diseases and glaucoma, the company said.

The startup’s ultimate goal is to make the sophisticated ophthalmic procedure more accessible internationally...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Robotics/RPA, Technology, Trends
Less pain, quicker recoveries: 1 year of University Hospitals' robotics push
Here’s The Second Humanoid Robot To Get A Paying Job
CES 2025: 20 Tech Experts Predict Highlights And Trends
Study explores factors influencing acceptance of home-care robots
FHC #157: NVIDIA expects AI, robots to cure healthcare’s biggest problems

Share This Article